Literature DB >> 22726895

Preoperative needle biopsy improves the quality of breast cancer surgery.

Ted A James1, John L Mace, Beth A Virnig, Berta M Geller.   

Abstract

BACKGROUND: Percutaneous needle biopsy has the potential to provide a preoperative diagnosis of breast cancer, which helps to optimize surgical planning; however, its use remains an area of unexplained clinical variation. The purposes of this study were to perform a statewide assessment of diagnostic biopsy methods for women diagnosed with breast cancer and to evaluate the impact of biopsy method on the quality of breast cancer surgery. STUDY
DESIGN: Vermont cancer registries were combined with Medicare data to identify women diagnosed with breast cancer between 1998 and 2006. Demographics, margin status, surgical evaluation of axillary nodes, and total number of operations were correlated to biopsy method.
RESULTS: Percutaneous needle biopsy (PNB) was the initial biopsy method in 713 (62.8%) patients, and it increased significantly over the study period. Patients living in urban settings were more likely to receive PNB (70.6%) than patients living in rural areas (57.5%). Breast cancer surgery performance metrics including margin status, number of operations, and performance of axillary evaluation significantly favored PNB over open biopsy (OB).
CONCLUSIONS: The quality of breast cancer surgery as measured by initial margin status, total number of operations, and axillary evaluation improved with preoperative PNB; however, the use of PNB varied considerably. The potential impact of PNB on the quality of patient care and health care costs is substantial. Emphasis should be placed on understanding the barriers to the use of preoperative PNB and developing strategies to expand its use in the management of breast cancer.
Copyright © 2012 American College of Surgeons. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22726895     DOI: 10.1016/j.jamcollsurg.2012.05.022

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN: 1072-7515            Impact factor:   6.113


  5 in total

1.  Breast cancer detection with short-interval follow-up compared with return to annual screening in patients with benign stereotactic or US-guided breast biopsy results.

Authors:  Jason M Johnson; Alisa K Johnson; Ellen S O'Meara; Diana L Miglioretti; Berta M Geller; Elise N Hotaling; Sally D Herschorn
Journal:  Radiology       Date:  2014-11-25       Impact factor: 11.105

2.  Gradual adoption of needle biopsy for breast lesions in a rural state.

Authors:  Serena Murphy; Yi-Chuan Yu; Colleen Kerrigan; Brian Sprague; Michelle Sowden
Journal:  Cancer Med       Date:  2021-11-09       Impact factor: 4.452

3.  Identifying key barriers to effective breast cancer control in rural settings.

Authors:  Brian L Sprague; Thomas P Ahern; Sally D Herschorn; Michelle Sowden; Donald L Weaver; Marie E Wood
Journal:  Prev Med       Date:  2021-07-22       Impact factor: 4.018

4.  Trends in breast biopsies for abnormalities detected at screening mammography: a population-based study in the Netherlands.

Authors:  V van Breest Smallenburg; J Nederend; A C Voogd; J W W Coebergh; M van Beek; F H Jansen; W J Louwman; L E M Duijm
Journal:  Br J Cancer       Date:  2013-05-21       Impact factor: 7.640

5.  Choosing Wisely Africa: Ten Low-Value or Harmful Practices That Should Be Avoided in Cancer Care.

Authors:  Fidel Rubagumya; Gunita Mitera; Sidy Ka; Achille Manirakiza; Philippa Decuir; Susan C Msadabwe; Solange Adani Ifè; Emmanuella Nwachukwu; Naomi Ohene Oti; Hirondina Borges; Miriam Mutebi; Dafalla Abuidris; Verna Vanderpuye; Christopher M Booth; Nazik Hammad
Journal:  JCO Glob Oncol       Date:  2020-07
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.